Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - August 2013


International Congress on Immunology, ICI 2013

22 Aug 2013 - 27 Aug 2013 - MiCo - Milano Congressi, Milan, Italy



Bookmark and Share


It will encompass basic research, translation and clinical application. It will interest both young students and experienced researchers. It will cover the full spectrum from academic research to industry.

The Congress, however, will not only serve as platform for communication and exchange of the most challenging state-of-the-art research among immunologists. It will also serve as impressive platform for making laypersons, the press and politicians aware of the importance of immunologic research for maintenance of well-being, and combat of major diseases, including infectious diseases, autoimmune diseases or allergic diseases. Last but not least, it will provide a unique platform for meeting colleagues/friends/post-doc candidates and mentors. In short, the 15th ICI will be wonderful meeting point for researchers from academia, industry and clinics both from industrialized and developing countries and hence strengthen existing friendships and invite new ones.

The 15th ICI will take place in Milan, Italy and this guarantees another wonderful aspect, namely, the great opportunity for social activities in a most accessible and welcoming city. Milan boasts a unique, world‐famous artistic heritage, of which the best known is Leonardo da Vinci’s Last Supper. Today Milan is not only the international centre of fashion and design, but also a vibrant city, which guarantees a lot of fun after a hard working day at the Congress.

SIICA represents over 1,000 immunologists active in Italy, and several of its members are recognized as international leaders in their field, actively contributing to the development of Immunology. Therefore, the scientific organization of the ICI will count on a dedicated and competent local scientific committee, in addition to a distinguished international committee.

The meeting will cover all aspects of Immunology, from the more traditional to the most innovative, with emphasis on translational aspects and clinical applications. A scientifically inspiring program will be assembled in a range of formats to cover a wide variety of interests and provide the state of the art in all different facets of Immunology. An introductory Immunology course just before the ICI, and satellite symposia at several locations in Italy will complement the scientific program.

Milan has a rich historic heritage, dating back to its times as capital of the Western Roman Empire. Leonardo da Vinci, the quintessential Renaissance polymath artist and scientist, while in the Milan area drew his iconic Vitruvian man shown in the 15th ICI logo. Today Milan is a dynamic and trendy city, a renowned international centre of fashion and design as well as of arts and science. The City has just opened the largest and most modern congress center in Europe , which will comfortably accommodate the ICI participants.



Further information
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!